کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
339350 548072 2010 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Elevated Serum Levels of Interleukin-10 and Tumor Necrosis Factor Are Both Associated With Vital Exhaustion in Patients With Cardiovascular Risk Factors
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی روانپزشکی و بهداشت روانی
پیش نمایش صفحه اول مقاله
Elevated Serum Levels of Interleukin-10 and Tumor Necrosis Factor Are Both Associated With Vital Exhaustion in Patients With Cardiovascular Risk Factors
چکیده انگلیسی

BackgroundVital exhaustion, a psychological state characterized by unusual fatigue, irritability, and feelings of demoralization, has been identified as a risk factor for cardiovascular diseases and linked to elevated levels of pro-inflammatory cytokines.ObjectiveThe purpose of this study was to investigate the relationship between vital exhaustion and cytokine levels in patients with cardiovascular risk factors.MethodThe entire cohort consisted of 356 primary-care patients with cardiovascular risk factors who participated in a study of early recognition of heart failure. All participants completed the Maastricht questionnaire (MQ) for assessing vital exhaustion. Cytokine serum levels were measured in all those subjects (N = 178) who were assigned to the highest and lowest quartiles of the MQ, respectively.ResultsElevated serum concentrations of interleukin-6 and tumor necrosis factorα, but not other cytokines, were associated with high MQ scores indicative of vital exhaustion.ConclusionThe subjective state of vital exhaustion is linked to a substantial alteration in the pattern of secreted cytokines. Data suggest that a disturbance in the levels of both pro-inflammatory and anti-inflammatory mediators, rather than isolated stimulation by pro-inflammatory cytokines, is associated with the mental and physical changes of vital exhaustion.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Psychosomatics - Volume 51, Issue 3, May–June 2010, Pages 248–256
نویسندگان
, , , , , , , , , , ,